Es gab 50 kürzliche Insider-Transaktionen für PMV Pharmaceuticals, Inc. (PMVP), darunter 26 Käufe und 19 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $5.6M und die gesamten Insider-Verkäufe auf $6.65M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Mack David Henry, Ticktin Robert, Jalota Deepika. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — PMVP
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-05 |
Mack David Henry |
President and CEO |
RSU-Zuteilung |
744,960 |
$1.53 |
$1.14M |
744,960 |
| 2026-03-05 |
Ticktin Robert |
General Counsel & COO |
RSU-Zuteilung |
319,270 |
$1.53 |
$488.48K |
319,270 |
| 2026-03-05 |
Jalota Deepika |
Chief Development Officer |
RSU-Zuteilung |
303,310 |
$1.53 |
$464.06K |
303,310 |
| 2026-03-05 |
Carulli Michael |
Chief Financial Officer |
RSU-Zuteilung |
240,000 |
$1.53 |
$367.2K |
240,000 |
| 2025-10-27 |
Mack David Henry |
President and CEO |
Optionsausübung (Verkauf) |
220,643 |
$1.37 |
$302.28K |
- |
| 2025-10-23 |
Orbimed Advisors Llc |
10 Percent Owner |
Informierter Verkauf |
1,000,000 |
$1.52 |
$1.52M |
4,975,291 |
| 2025-09-10 |
Orbimed Advisors Llc |
10 Percent Owner |
Informierter Verkauf |
500,000 |
$1.80 |
$900K |
5,975,291 |
| 2025-07-01 |
Mack David Henry |
President and CEO |
Informierter Verkauf |
58,411 |
$1.06 |
$62.18K |
536,133 |
| 2025-07-01 |
Ticktin Robert |
General Counsel & COO |
Informierter Verkauf |
23,151 |
$1.06 |
$24.65K |
98,695 |
| 2025-07-01 |
Jalota Deepika |
Chief Development Officer |
Informierter Verkauf |
33,065 |
$1.06 |
$35.2K |
89,959 |
| 2025-07-01 |
Carulli Michael |
Chief Financial Officer |
Informierter Verkauf |
28,249 |
$1.06 |
$30.08K |
60,146 |
| 2025-06-05 |
Levine Arnold J |
Director |
RSU-Zuteilung |
33,500 |
$0.95 |
$31.83K |
33,500 |
| 2025-06-05 |
Gallagher Carol Giltner |
Director |
Schenkung (gegeben) |
33,500 |
$0.95 |
$31.83K |
- |
| 2025-06-05 |
Baum Charles M |
Director |
RSU-Zuteilung |
33,500 |
$0.95 |
$31.83K |
33,500 |
| 2025-06-05 |
Heyman Richard A. |
Director |
RSU-Zuteilung |
33,500 |
$0.95 |
$31.83K |
33,500 |
| 2025-06-05 |
Stelzer Laurie |
Director |
RSU-Zuteilung |
33,500 |
$0.95 |
$31.83K |
33,500 |
| 2025-06-05 |
Flowers Kirsten |
Director |
RSU-Zuteilung |
33,500 |
$0.95 |
$31.83K |
33,500 |
| 2025-04-21 |
Ticktin Robert |
General Counsel & COO |
Unbekannt |
265,000 |
$1.32 |
$349.8K |
- |
| 2025-03-03 |
Mack David Henry |
President and CEO |
RSU-Zuteilung |
800,000 |
$1.32 |
$1.06M |
800,000 |
| 2025-03-03 |
Jalota Deepika |
Chief Development Officer |
RSU-Zuteilung |
300,000 |
$1.32 |
$396K |
300,000 |
| 2025-03-03 |
Carulli Michael |
Chief Financial Officer |
RSU-Zuteilung |
265,000 |
$1.32 |
$349.8K |
265,000 |
| 2025-01-03 |
Mack David Henry |
President and CEO |
Optionsausübung (Verkauf) |
17,709 |
$0.53 |
$9.39K |
- |
| 2024-12-03 |
Mack David Henry |
President and CEO |
Optionsausübung (Verkauf) |
91,750 |
$0.53 |
$48.63K |
17,709 |
| 2024-09-11 |
Jalota Deepika |
Chief Development Officer |
Informierter Verkauf |
7,218 |
$1.50 |
$10.85K |
118,283 |
| 2024-09-11 |
Carulli Michael |
Chief Financial Officer |
Informierter Verkauf |
2,891 |
$1.50 |
$4.35K |
88,395 |
| 2024-08-13 |
Mack David Henry |
President and CEO |
Aktienrückgabe |
330,000 |
$5.70 |
$1.88M |
- |
| 2024-08-13 |
Jalota Deepika |
Chief Development Officer |
Aktienrückgabe |
22,674 |
$28.33 |
$642.35K |
- |
| 2024-08-13 |
Carulli Michael |
Chief Financial Officer |
Aktienrückgabe |
13,605 |
$28.33 |
$385.43K |
- |
| 2024-06-07 |
Gallagher Carol Giltner |
Director |
Schenkung (gegeben) |
67,500 |
$1.65 |
$111.38K |
- |
| 2024-06-06 |
Levine Arnold J |
Director |
RSU-Zuteilung |
67,500 |
$1.65 |
$111.38K |
67,500 |
| 2024-06-06 |
Gallagher Carol Giltner |
Director |
RSU-Zuteilung |
67,500 |
$1.65 |
$111.38K |
67,500 |
| 2024-06-06 |
Baum Charles M |
Director |
RSU-Zuteilung |
67,500 |
$1.65 |
$111.38K |
67,500 |
| 2024-06-06 |
Heyman Richard A. |
Director |
RSU-Zuteilung |
67,500 |
$1.65 |
$111.38K |
67,500 |
| 2024-06-06 |
Stelzer Laurie |
Director |
RSU-Zuteilung |
67,500 |
$1.65 |
$111.38K |
67,500 |
| 2024-06-06 |
Flowers Kirsten |
Director |
RSU-Zuteilung |
67,500 |
$1.65 |
$111.38K |
67,500 |
| 2024-01-18 |
Mack David Henry |
President and CEO |
RSU-Zuteilung |
163,890 |
- |
- |
442,460 |
| 2024-01-18 |
Jalota Deepika |
Chief Development Officer |
RSU-Zuteilung |
95,555 |
- |
- |
125,501 |
| 2024-01-18 |
Carulli Michael |
Chief Financial Officer |
RSU-Zuteilung |
82,220 |
- |
- |
91,286 |
| 2024-01-05 |
Carulli Michael |
Chief Financial Officer |
Veräußerung |
75,000 |
$5.70 |
$427.5K |
- |
| 2023-11-22 |
Orbimed Advisors Llc |
10 Percent Owner |
Informierter Verkauf |
87,786 |
$2.23 |
$195.76K |
- |
| 2023-11-10 |
Mack David Henry |
President and CEO |
Schenkung (erhalten) |
85,307 |
- |
- |
165,307 |
| 2023-10-18 |
Mack David Henry |
President and CEO |
Optionsausübung |
198,407 |
$0.53 |
$105.16K |
363,877 |
| 2023-09-15 |
Jalota Deepika |
Chief Development Officer |
Informierter Verkauf |
4,104 |
$6.62 |
$27.17K |
29,946 |
| 2023-09-15 |
Alland Leila |
Chief Medical Officer |
Informierter Verkauf |
6,291 |
$6.62 |
$41.65K |
45,909 |
| 2023-08-07 |
Mack David Henry |
President and CEO |
Optionsausübung |
85,500 |
$0.53 |
$45.32K |
165,470 |
| 2023-08-07 |
Mack David Henry |
President and CEO |
Optionsausübung (Verkauf) |
198,407 |
$0.53 |
$105.16K |
109,459 |
| 2023-06-08 |
Levine Arnold J |
Director |
RSU-Zuteilung |
21,500 |
$5.59 |
$120.19K |
21,500 |
| 2023-06-08 |
Gallagher Carol Giltner |
Director |
Schenkung (gegeben) |
21,500 |
$5.59 |
$120.19K |
- |
| 2023-06-08 |
Baum Charles M |
Director |
RSU-Zuteilung |
21,500 |
$5.59 |
$120.19K |
21,500 |
| 2023-06-08 |
Heyman Richard A. |
Director |
RSU-Zuteilung |
21,500 |
$5.59 |
$120.19K |
21,500 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
